Barden, A.O Callaghan, N.Burke, V.Mas, E.Beilin, L.J.Fenech, M.Irish, A.B.Watts, G.F.Puddey, I.B.Huang, R.C.Mori, T.A.2017-03-272017-03-272016Nutrients, 2016; 8(3):1-112072-66432072-6643http://hdl.handle.net/2440/104031DNA telomere shortening associates with the age-related increase cardiovascular disease (CVD) risk. Reducing oxidative stress, could modify telomere erosion during cell replication, and CVD risk in patients with chronic kidney disease (CKD). The effect of n-3 fatty acids and coenzyme Q10 (CoQ) on telomere length was studied in a double-blind placebo-controlled trial in CKD. Eighty-five CKD patients were randomized to: n-3 fatty acids (4 g); CoQ (200 mg); both supplements; or control (4 g olive oil), daily for 8 weeks. Telomere length was measured in neutrophils and peripheral blood mononuclear cells (PBMC) at baseline and 8 weeks, with and without correction for cell counts. Main and interactive effects of n-3 fatty acids and CoQ on telomere length were assessed adjusting for baseline values. F2-isoprostanes were measured as markers of oxidative stress. There was no effect of n-3 fatty acids or CoQ on neutrophil or PBMC telomere length. However, telomere length corrected for neutrophil count was increased after n-3 fatty acids (p = 0.015). Post-intervention plasma F2-isoprostanes were negative predictors of post-intervention telomere length corrected for neutrophil count (p = 0.025).The effect of n-3 fatty acids to increased telomere length corrected for neutrophil count may relate to reduced oxidative stress and increased clearance of neutrophils with shorter telomeres from the circulation. This may be a novel mechanism of modifying CVD risk in CKD patients.en© 2016 by the authors; licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons by Attribution (CC-BY) license (http://creativecommons.org/licenses/by/4.0/).neutrophils; telomere length; oxidative stress; n-3 fatty acids; coenzyme Q10n-3 fatty acid supplementation and leukocyte telomere length in patients with chronic kidney diseaseJournal article003005792510.3390/nu80301750003735285000692-s2.0-84962558072277347Mas, E. [0000-0003-2848-9613]Fenech, M. [0000-0002-8466-0991]